Skip to main content
. 2023 Feb 24;14:1118793. doi: 10.3389/fphar.2023.1118793

TABLE 2.

Summary of antibiotic resistant mechanisms in MRSA.

Antibiotic class Resistant mechanism
Penicillins and 4 generation of Cephalosporins Penicillinase, production of PBP2a
Carbapenems Development of PBP2a
Tetracyclines Ribosomal methylation of binding sites, efflux pumps
Tigecyclines Efflux pumps
Macrolides and clindamycin Ribosomal methylation of binding sites, efflux pumps
Fluoroquinolones Mutations in topoisomerase IV and DNA gyrase, efflux pumps
Rifampicin Mutations in RNA polymerase gene
TMP/SMX Mutations in DHPS and DHFR
Aminoglycosides Aminoglycoside degradation enzymes
Daptomycin Electrostatic repulsion through increase to the cell-surface charge
Vancomycin VRSA: altered structure of peptidoglycan precursors from D-Ala-D-Ala to D-Ala-D-Lac; VISA: increased production of peptidoglycan, thicker cell wall, decoy D-Ala-D-Ala dipeptides on cell surface
Linezolid Mutations to the 23S rRNA, altering required modifications to the 23S rRNA, mutations to the 50S ribosomal L3 protein

Abbreviations: PBP, penicillin binding protein; TMP/SMX, trimethoprim-sulfamethoxazole; DHPS, dihydropteroate synthase; DHFR, dihydrofolate reductase.